Jana Lass

407 total citations
20 papers, 271 citations indexed

About

Jana Lass is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Jana Lass has authored 20 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Nephrology. Recurrent topics in Jana Lass's work include Pharmaceutical studies and practices (9 papers), Neonatal Respiratory Health Research (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Jana Lass is often cited by papers focused on Pharmaceutical studies and practices (9 papers), Neonatal Respiratory Health Research (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Jana Lass collaborates with scholars based in Estonia, United Kingdom and Finland. Jana Lass's co-authors include Irja Lutsar, Heili Varendi, Tuuli Metsvaht, M. Turner, Alar Irs, Anthony J Nunn, Utpal Shah, Kaisa Naelapää, Karolin Toompere and Koit Herodes and has published in prestigious journals such as Archives of Disease in Childhood, Analytical and Bioanalytical Chemistry and Journal of Psychiatric Research.

In The Last Decade

Jana Lass

18 papers receiving 259 citations

Peers

Jana Lass
Smita Salunke United Kingdom
Siri Wang Norway
Jennifer C Duncan United Kingdom
Wanli Zhuang Germany
Tony Nunn United Kingdom
Shireen Banerji United States
Daniel Grams Germany
Nina Griese Germany
Smita Salunke United Kingdom
Jana Lass
Citations per year, relative to Jana Lass Jana Lass (= 1×) peers Smita Salunke

Countries citing papers authored by Jana Lass

Since Specialization
Citations

This map shows the geographic impact of Jana Lass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Lass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Lass more than expected).

Fields of papers citing papers by Jana Lass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jana Lass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Lass. The network helps show where Jana Lass may publish in the future.

Co-authorship network of co-authors of Jana Lass

This figure shows the co-authorship network connecting the top 25 collaborators of Jana Lass. A scholar is included among the top collaborators of Jana Lass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana Lass. Jana Lass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lass, Jana, et al.. (2025). Model-Informed Dose Optimization of Spironolactone in Neonates and Infants. Pharmaceuticals. 18(3). 355–355.
2.
Laaksonen, Raisa, et al.. (2024). Medication Safety in Intensive Care Settings across Europe – Focus Group Discussions. Research in Social and Administrative Pharmacy. 20(2). 226–226. 1 indexed citations
3.
Laaksonen, Raisa, et al.. (2024). Patient safety culture and medication safety in European intensive care units: a focus group study. European Journal of Hospital Pharmacy. 32(3). 209–219.
4.
Kasela, Silva, Tuuli Jürgenson, Aet Saar, et al.. (2023). The role of depression and antidepressant treatment in antihypertensive medication adherence and persistence: Utilising electronic health record data. Journal of Psychiatric Research. 168. 269–278. 6 indexed citations
5.
Lass, Jana, Stéphanie Leroux, Heili Varendi, et al.. (2023). Pharmacokinetics of oral spironolactone in infants up to 2 years of age. European Journal of Clinical Pharmacology. 80(2). 239–248. 1 indexed citations
6.
Soeorg, Hiie, et al.. (2022). Estimation of cefepime, piperacillin, and tazobactam clearance with iohexol-based glomerular filtration rate in paediatric patients. European Journal of Clinical Pharmacology. 78(6). 989–1001. 2 indexed citations
8.
Lass, Jana, Tuuli Metsvaht, Heili Varendi, et al.. (2019). Medicines prescription patterns in European neonatal units. International Journal of Clinical Pharmacy. 41(6). 1578–1591. 7 indexed citations
9.
Lass, Jana, Kadri Tamme, Karin Kipper, & Joel Starkopf. (2017). Dosing of Ertapenem in an Extreme Obesity: A Case Report of 250 kg Patient. Case Reports in Critical Care. 2017. 1–3. 1 indexed citations
10.
Kogermann, Karin, et al.. (2017). Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines. Current Pharmaceutical Design. 23(38). 5779–5789. 10 indexed citations
11.
Aro, Rudolf, et al.. (2017). Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH4F as eluent additives. Analytical and Bioanalytical Chemistry. 409(12). 3145–3151. 35 indexed citations
12.
Metsvaht, Tuuli, Heili Varendi, Jana Lass, et al.. (2016). Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates. Pediatric Drugs. 18(3). 221–230. 10 indexed citations
13.
Metsvaht, Tuuli, Heili Varendi, Karolin Toompere, et al.. (2015). Potentially harmful excipients in neonatal medicines: a pan-European observational study. Archives of Disease in Childhood. 100(7). 694–699. 50 indexed citations
14.
Selby, Andrew, R.C. Garner, Caroline J. Earnshaw, et al.. (2014). ABSTRACT 707. Pediatric Critical Care Medicine. 15. 160–160. 1 indexed citations
15.
Lass, Jana, Viveca Odlind, Alar Irs, & Irja Lutsar. (2013). Antibiotic prescription preferences in paediatric outpatient setting in Estonia and Sweden. SpringerPlus. 2(1). 124–124. 13 indexed citations
16.
Lass, Jana, Kaisa Naelapää, Utpal Shah, et al.. (2012). Hospitalised neonates in Estonia commonly receive potentially harmful excipients. BMC Pediatrics. 12(1). 136–136. 42 indexed citations
17.
Lass, Jana, Kaisa Naelapää, & Irja Lutsar. (2012). Hospitalised Estonian newborns are exposed to a significant amount of potentially toxic excipients. European Journal of Hospital Pharmacy. 19(2). 227.2–227. 1 indexed citations
18.
Lass, Jana, et al.. (2011). Drug utilisation pattern and off-label use of medicines in Estonian neonatal units. European Journal of Clinical Pharmacology. 67(12). 1263–1271. 57 indexed citations
19.
Lass, Jana, et al.. (2011). Off label use of prescription medicines in children in outpatient setting in Estonia is common. Pharmacoepidemiology and Drug Safety. 20(5). 474–481. 26 indexed citations
20.
Lass, Jana, Andres Männik, & J. Simon Bell. (2008). Pharmacotherapy of first episode psychosis in Estonia: comparison with national and international treatment guidelines. Journal of Clinical Pharmacy and Therapeutics. 33(2). 165–173. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026